Navigation Links
Experts recommend men at risk for osteoporosis undergo bone density testing
Date:6/18/2012

Chevy Chase, MDOsteoporosis in men causes significant morbidity and mortality. Today, the Endocrine Society released clinical practice guidelines (CPG) for management of this condition in men. "Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline," is published in the June 2012 issue of the Journal of Clinical Endocrinology and Metabolism (JCEM), a publication of The Endocrine Society.

Osteoporosis is a silent disorder characterized by reduced bone strength predisposing to increased fracture risk. Approximately 20 percent of Americans with osteoporosis or low bone density are men and studies show this condition increases mortality rates in men between the ages of 50 and 69. Risk factors for osteoporosis in men include low body weight, prior fracture as an adult and smoking.

"For men age 50, one in 5 will experience an osteoporosis-related fracture in their lifetime," said Nelson Watts, MD, of Mercy Health Osteoporosis and Bone Health Services in Cincinnati, OH and chair of the task force that authored the CPG. "Mortality after fracture is higher in men than in women. Of the 10 million Americans with osteoporosis, 2 million are men. Of the 2 million fractures due to osteoporosis that occur each year, 600,000 are in men."

Recommendations from the CPG include:

  • Men at higher risk for osteoporosis (including men aged 70 years or older and men between the ages of 50 and 69 who have risk factors) should be tested using dual-energy x-ray absorptiometry (DXA);
  • Men with low vitamin D levels [<30 ng/ml] should receive vitamin D supplementation to achieve levels of at least 30 ng/ml;
  • Pharmacologic treatment should be given to men aged 50 or older who have had spine or hip fractures and men at high risk of fracture based on low bone mineral density and/or clinical risk factors;
  • Clinicians should monitor bone mineral density by DXA at the spine and hip every one to two years to assess the response to treatment; and
  • Men who are at risk for osteoporosis should consume 1000 1200 mg of calcium daily, ideally from dietary sources, with calcium supplements added if dietary calcium is insufficient.


'/>"/>
Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

Related medicine news :

1. Bioinformatics experts at the CNIO explore additional coding potential hidden in the human genome
2. University Hospitals Case Medical Center experts present at ASCO Annual Meeting
3. Mayo Clinic, youth mental health experts, publish new guidelines to treat childhood aggression
4. Brave New World of Genetics Requires Safeguards, Experts Say
5. British experts update addiction treatment guidelines
6. Experts call for clinical trials to test non-skeletal benefits of vitamin D
7. Aim Skin Cancer Warnings at the Young, Too, Experts Say
8. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
9. Routine Kidney Disease Screening Not Worthwhile, Experts Say
10. Healthy Behaviors Extend Life After Cancer, Experts Say
11. Glaucoma Need Not Steal Sight, Experts Say
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , developer of ... Med-e-Mass , the largest Electronic Medical Records (EMR) provider in South Africa. ... incentives to a patient’s remote health progress, empowering the patient to take direct responsibility ...
(Date:4/26/2017)... ... ... Infertility may be a result of an underlying pelvic ... become pregnant upon treating their diagnosis. , To properly diagnose patients, ... can provide the necessary information to diagnose and treat your problem. , ...
(Date:4/26/2017)... ... April 26, 2017 , ... Want to learn ... ( CRISPRCas.pioneer.com ) that demonstrates how this advanced plant breeding technology is a ... food, with fewer resources. It highlights the business’ principles, research and collaboration efforts ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, a ... announce that it has received 510(k) clearance from the U.S. Food & Drug ... MyoCycle Pro. , Both devices are stationary cycling systems that use MYOLYN’s patent-pending ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... they have signed an agreement to be the preferred physical therapy provider for ... and returning them to Derby City CrossFit as quickly and effectively as possible, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
Breaking Medicine Technology: